These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27404108)

  • 21. Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells.
    Grabski E; Wappler I; Pfaender S; Steinmann E; Haid S; Dzionek A; Pietschmann T; Kalinke U
    J Virol; 2015 Mar; 89(6):3200-8. PubMed ID: 25552725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.
    Wang Y; Li J; Wang X; Ye L; Zhou Y; Thomas RM; Ho W
    Innate Immun; 2014 Jan; 20(1):3-11. PubMed ID: 23529855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus ARFP/F protein interacts with cellular MM-1 protein and enhances the gene trans-activation activity of c-Myc.
    Ma HC; Lin TW; Li H; Iguchi-Ariga SM; Ariga H; Chuang YL; Ou JH; Lo SY
    J Biomed Sci; 2008 Jul; 15(4):417-25. PubMed ID: 18398700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production and pathogenicity of hepatitis C virus core gene products.
    Li HC; Ma HC; Yang CH; Lo SY
    World J Gastroenterol; 2014 Jun; 20(23):7104-22. PubMed ID: 24966583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression studies of the HCV-1a core+1 open reading frame in mammalian cells.
    Vassilaki N; Boleti H; Mavromara P
    Virus Res; 2008 May; 133(2):123-35. PubMed ID: 18243391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular localizations of the hepatitis C virus alternate reading frame proteins.
    Ratinier M; Boulant S; Crussard S; McLauchlan J; Lavergne JP
    Virus Res; 2009 Jan; 139(1):106-10. PubMed ID: 18996421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication.
    Giugliano S; Kriss M; Golden-Mason L; Dobrinskikh E; Stone AE; Soto-Gutierrez A; Mitchell A; Khetani SR; Yamane D; Stoddard M; Li H; Shaw GM; Edwards MG; Lemon SM; Gale M; Shah VH; Rosen HR
    Gastroenterology; 2015 Feb; 148(2):392-402.e13. PubMed ID: 25447848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells.
    Eksioglu EA; Zhu H; Bayouth L; Bess J; Liu HY; Nelson DR; Liu C
    PLoS One; 2011; 6(6):e21186. PubMed ID: 21695051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
    Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
    mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response.
    Tasaka M; Sakamoto N; Itakura Y; Nakagawa M; Itsui Y; Sekine-Osajima Y; Nishimura-Sakurai Y; Chen CH; Yoneyama M; Fujita T; Wakita T; Maekawa S; Enomoto N; Watanabe M
    J Gen Virol; 2007 Dec; 88(Pt 12):3323-3333. PubMed ID: 18024902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions.
    Walewski JL; Gutierrez JA; Branch-Elliman W; Stump DD; Keller TR; Rodriguez A; Benson G; Branch AD
    RNA; 2002 May; 8(5):557-71. PubMed ID: 12022223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.
    Basu A; Meyer K; Ray RB; Ray R
    Virology; 2001 Sep; 288(2):379-90. PubMed ID: 11601909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
    Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
    Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes.
    Wang Y; Li J; Wang X; Ye L; Zhou Y; Ho W
    J Viral Hepat; 2013 Jun; 20(6):385-94. PubMed ID: 23647955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.
    Schnell G; Loo YM; Marcotrigiano J; Gale M
    PLoS Pathog; 2012; 8(8):e1002839. PubMed ID: 22912574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus alternative reading frame protein (ARFP): Production, features, and pathogenesis.
    Mohamadi M; Azarbayjani K; Mozhgani SH; Bamdad T; Alamdary A; Nikoo HR; Hashempour T; Hedayat Yaghoobi M; Ajorloo M
    J Med Virol; 2020 Dec; 92(12):2930-2937. PubMed ID: 32470157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.